Lab sector loses its oomph
publication date: Feb 28, 2011
Organic growth in the German lab market in 2010 was disappointingly weak. Deutsche Bank analyst David Low reckons that Sonic Healthcare managed no more than 1% sales growth in value, with Switzerland and Belgium also looking soft. Another competitor told us that, if Sonic had managed 1% organic sales growth, it was doing well. Meanwhile French legislators may yet halt lab consolidation. The UK remains the only sweet spot, as the sector loses its sex appeal.
To get full access to this article you will need to subscribe to Healthcare Europa. This gives you indepth quality coverage of how the dynamic private healthcare sector is developing across Europe.
Please click here to look at subscription options.
You can, however, register for free to recieve limited access. This gives you access to headlines and the first lines of stories and you can ask us to send you a news email with headlines 40 times a year. As a free registrant, you can also view our blog. Click here to sign up for limited access free registration.
